Akoya announces rollout of strategic clinical research program to advance adoption of spatial biology for clinical applications

Company launches advanced biopharma solutions (abs), as the first pillar of the program, to enable spatial biomarker-guided drug development and clinical trials company launches advanced biopharma solutions (abs), as the first pillar of the program, to enable spatial biomarker-guided drug development and clinical trials

AKYA Ratings Summary

AKYA Quant Ranking